Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021538 · ClinicalTrials.gov registry record
Bypass vs. Ecmo in Lung Transplantation (BELT)
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 13
- Enrollment target
NCT03021538: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT03021538 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021538 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study seeks to compare outcomes of 2 different methods of cardiopulmonary support during lung transplant surgeries.
Primary Outcome
Number of pRBC transfusion that resulted due to postoperative bleeding
Interventions
- DEVICE Extracorporeal Membrane Oxygenation
- DEVICE Cardiopulmonary Bypass
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2019-01-24 |
Why NCT03021538 stopped before completion
NCT03021538 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Extracorporeal Membrane Oxygenation is the first listed.
NCT03021538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03021538 about?
NCT03021538 is a clinical study titled "Bypass vs. Ecmo in Lung Transplantation (BELT)". This study seeks to compare outcomes of 2 different methods of cardiopulmonary support during lung transplant surgeries.
What is the current status of trial NCT03021538?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2017-04-17. Estimated completion is 2019-01-24.
What interventions are being tested in trial NCT03021538?
The interventions under investigation include: Extracorporeal Membrane Oxygenation (DEVICE), Cardiopulmonary Bypass (DEVICE).
Who is sponsoring clinical trial NCT03021538?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI